Literature DB >> 11813235

Central nervous system myelination in mice with deficient expression of Notch1 receptor.

Maria I Givogri1, Rui M Costa, Vilma Schonmann, Alcino J Silva, Anthony T Campagnoni, Ernesto R Bongarzone.   

Abstract

Activity of the Notch1 gene is known to inhibit oligodendrocyte (OL) differentiation in vitro. We tested the hypothesis that the Notch1 pathway regulates in vivo myelin formation, by examining brain myelination of Notch1 receptor null heterozygotes mutant animals (Notch1(+/-)). We show that a deficiency in Notch1 expression leads to increased abundance of products of specific myelin genes in myelinated areas of the brain during the first 2 weeks of postnatal life. We observed increased numbers of myelinated axons in optic nerves and the presence of myelinated fibers in the molecular layer (ML) of the Notch1(+/-) cerebella. These findings were accompanied by up-regulation of Mash1 and down-regulation of Hes5 proteins. In addition, we found expression of Jagged1, one of the Notch1 activators, in unmyelinated axons of the cerebellar ML during normal development. Our findings indicate that the Jagged/Notch signaling pathway might actively participate in the regulation of myelination during central nervous system development and suggest that certain neuronal populations might regulate whether their axons are myelinated by the expression of inhibitory signals such as Jagged1. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11813235     DOI: 10.1002/jnr.10128

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  44 in total

Review 1.  Axonal signals and oligodendrocyte differentiation.

Authors:  Maura Bozzali; Lawrence Wrabetz
Journal:  Neurochem Res       Date:  2004-05       Impact factor: 3.996

Review 2.  Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis.

Authors:  Kelly A Chamberlain; Sonia E Nanescu; Konstantina Psachoulia; Jeffrey K Huang
Journal:  Neuropharmacology       Date:  2015-10-22       Impact factor: 5.250

3.  Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron.

Authors:  Hui-Teng Cheng; Mijin Kim; M Todd Valerius; Kameswaran Surendran; Karin Schuster-Gossler; Achim Gossler; Andrew P McMahon; Raphael Kopan
Journal:  Development       Date:  2007-01-17       Impact factor: 6.868

Review 4.  How histone deacetylases control myelination.

Authors:  Claire Jacob; Frédéric Lebrun-Julien; Ueli Suter
Journal:  Mol Neurobiol       Date:  2011-08-23       Impact factor: 5.590

5.  Effects of varying Notch1 signal strength on embryogenesis and vasculogenesis in compound mutant heterozygotes.

Authors:  Changhui Ge; Pamela Stanley
Journal:  BMC Dev Biol       Date:  2010-03-29       Impact factor: 1.978

Review 6.  Extracellular cues influencing oligodendrocyte differentiation and (re)myelination.

Authors:  Natalie A Wheeler; Babette Fuss
Journal:  Exp Neurol       Date:  2016-03-23       Impact factor: 5.330

Review 7.  Transcriptional and Epigenetic Regulation of Oligodendrocyte Development and Myelination in the Central Nervous System.

Authors:  Ben Emery; Q Richard Lu
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-07-01       Impact factor: 10.005

Review 8.  Regulation of the timing of oligodendrocyte differentiation: mechanisms and perspectives.

Authors:  Hao Huang; Xiao-Feng Zhao; Kang Zheng; Mengsheng Qiu
Journal:  Neurosci Bull       Date:  2013-02-28       Impact factor: 5.203

9.  Role of aspartyl-(asparaginyl)-β-hydroxylase mediated notch signaling in cerebellar development and function.

Authors:  Elizabeth Silbermann; Peter Moskal; Nathaniel Bowling; Ming Tong; Suzanne M de la Monte
Journal:  Behav Brain Funct       Date:  2010-11-04       Impact factor: 3.759

10.  Notch signaling is required for activity-dependent synaptic plasticity at the Drosophila neuromuscular junction.

Authors:  Benjamin Lovegren de Bivort; Hui-Fu Guo; Yi Zhong
Journal:  J Neurogenet       Date:  2009       Impact factor: 1.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.